中国核能电力股份有限公司2025年第三季度报告 证券代码：601985 证券简称：中国核电 中国核能电力股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 注："本报告期"指本季度初至本季度末 3 个月期间，下同。 （二） 非经常性损益项目和金额 √适用 □不适用 单位:元 币种:人民币 | 非经常性损益项目 | 本期金额 | 年初至报告期末金额 | 说明 | | --- | --- | --- | --- | | 非流动性资产处置损益，包括已计提资产 | 1,521,679.32 | -2,330,308.85 | | | ...

中公高科养护科技股份有限公司 2025 年第三季度报告 证券代码：603860 证券简称：中公高科 中公高科养护科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 | | | | 单位：元 | 币种：人民币 | | --- | --- | --- | --- | --- | | | | 本报告期 | | 年初至报告期 | | 项目 | 本报告期 | 比上年同 | 年初至报告 | 末比上年同期 | | | | 期增减变 | 期末 | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 30,444,06 ...

Financial Performance - The company's revenue for Q3 2025 reached ¥740,006,615.79, an increase of 18.43% compared to the same period last year[5] - Net profit attributable to shareholders was ¥36,211,036.48, a significant increase of 362.41% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥30,356,004.13, up 735.73% from the previous year[5] - Basic and diluted earnings per share were both ¥0.19, reflecting a growth of 216.67% year-on-year[5] - For the first three quarters of 2025, the company achieved operating revenue of CNY 246,434.38 million, a year-on-year increase of 15.65%[12] - The net profit attributable to shareholders for the same period was CNY 24,912.05 million, reflecting a significant year-on-year increase of 92.48%[12] - Total operating revenue for the current period reached ¥2,464,343,777.17, an increase of 15.7% compared to ¥2,130,875,618.85 in the previous period[23] - Operating profit for the current period was ¥300,754,298.23, compared to ¥163,976,171.06 in the previous period, indicating a significant increase of 83.3%[23] - The total profit for the current period is 249,120,508.25, compared to 129,429,837.86 in the previous period, representing an increase of approximately 92.5%[24] - The basic and diluted earnings per share for the current period are both 1.27, up from 0.92 in the previous period, reflecting an increase of approximately 38.0%[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,418,127,128.52, representing a 29.52% increase from the end of the previous year[5] - Total assets rose to ¥2,418,127,128.52, up from ¥1,866,997,188.81, marking an increase of 29.5%[21] - Total liabilities increased to ¥2,021,018,623.82 from ¥1,579,022,735.96, reflecting a growth of 28.0%[20] - The company's equity attributable to shareholders increased by 37.90% to ¥397,108,504.70 compared to the end of the previous year[5] - Total equity attributable to shareholders reached ¥397,108,504.70, compared to ¥287,974,452.85, an increase of 38.0%[21] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥651,643,535.89, down 27.00% compared to the same period last year[9] - The net cash flow from operating activities is 651,643,535.89, down from 892,676,267.40 in the previous period, indicating a decrease of about 27%[25] - The cash inflow from investment activities is 2,159,890,236.53, compared to 1,912,303,337.07 in the previous period, showing an increase of approximately 12.9%[25] - The net cash flow from financing activities is -224,348,831.67, worsening from -175,362,476.05 in the previous period[26] - The total cash and cash equivalents at the end of the period amount to 411,993,889.22, compared to 381,324,959.90 at the end of the previous period, an increase of about 8.0%[26] Research and Development - Research and development expenses increased by 160.41% year-on-year, totaling ¥145,147,765.28, due to an increase in R&D personnel and employee costs[8] - Research and development expenses surged to ¥145,147,765.28, up from ¥55,738,255.36, indicating a growth of 160.0%[23] Shareholder Information - The company has 6,351 common shareholders at the end of the reporting period[10] - The largest shareholder, Tianjin Huatu Hongyang Enterprise Management Co., Ltd., holds 51.00% of the shares, with 71,678,760 shares pledged[10] - The company repurchased a total of 3,815,563 shares, accounting for 1.94% of the total share capital, with a total transaction amount of CNY 260,232,397.93[13][14] - The maximum and minimum repurchase prices were CNY 73.00 and CNY 63.91 per share, respectively[13] - The 2025 employee stock ownership plan involved 221 participants, with a total subscription amount of CNY 121,106,000[16] - The company adjusted the grant price of the 2025 restricted stock incentive plan from CNY 45.91 to CNY 32.76 per share[15] - The total number of restricted stocks to be granted was adjusted from 272.27 million shares to 381.178 million shares[15] Other Information - The company reported a significant increase in asset disposal gains, amounting to ¥11,043,051.88, a rise of 3191.37% compared to the previous year[8] - The company experienced a 180.29% increase in taxes payable, totaling ¥53,510,955.87, driven by profit growth[8] - Inventory decreased to ¥16,871,110.19 from ¥23,608,442.90, a decline of 28.6%[20] - Short-term borrowings were not reported, indicating a potential focus on maintaining liquidity[20] - The company has not executed any mergers or acquisitions during the reporting period[27] - The financial report for the third quarter has not been audited[27]

Financial Performance - The company's operating revenue for the third quarter reached ¥97,374.41 million, an increase of 19.09% compared to the same period last year[4] - The net profit attributable to shareholders was ¥1,906.47 million, representing a significant increase of 52.34% year-on-year[4] - The total profit for the period was reported at -¥2,451.50 million, with no applicable year-on-year comparison due to the nature of the loss[4] - The company achieved a turnaround in net profit for the third quarter, reporting ¥1,906.47 million compared to a loss of ¥4,598.94 million in the previous quarter[8] - The net profit attributable to shareholders was a loss of CNY 10,796.05 million, an increase in loss of CNY 5,361.85 million year-on-year[14] - Net profit for the first three quarters of 2025 was a loss of ¥143,429,335.68, compared to a loss of ¥128,914,011.21 in the same period of 2024[22] - The company reported a net loss attributable to the parent company of ¥107,960,515.10 for the current period, compared to a loss of ¥54,341,985.28 in the previous year[23] - Basic and diluted earnings per share were both -¥0.16, worsening from -¥0.08 in the same period last year[23] Revenue and Sales - The company achieved operating revenue of CNY 263,952.59 million, a year-on-year increase of 15.94%[14] - Revenue from semiconductor silicon wafers reached CNY 197,596.99 million, up 19.66% year-on-year, with a sales volume of 1,453.39 million 6-inch equivalent wafers, a 32.54% increase[14] - Sales of 12-inch silicon wafers were 127.79 million pieces, representing a 69.70% increase year-on-year[14] - Revenue from semiconductor power device chips was CNY 63,412.21 million, a slight decline of 0.86% year-on-year, with sales volume of 144.15 million pieces, up 10.21%[14] - Revenue from compound semiconductor RF and optoelectronic chips was CNY 21,443.83 million, a 6.19% increase year-on-year, despite a 7.86% decrease in sales volume[15] - The average selling price of products increased by 15.25% year-on-year, despite a reduction in sales volume due to adjustments in product sales structure[15] Costs and Expenses - Total operating costs increased to ¥2,882,632,784.22, up 17.1% from ¥2,459,823,397.02 year-over-year[21] - The company recorded depreciation and amortization expenses of CNY 82,116.75 million, an increase of CNY 12,672.15 million year-on-year[15] - Research and development expenses for the first three quarters of 2025 were ¥193,390,181.05, a decrease of 5.2% from ¥203,992,519.05 in 2024[21] - The company reported an increase in financial expenses to ¥211,666,383.33, up from ¥169,255,354.50, indicating a rise of 25.1%[21] Cash Flow and Assets - The cash flow from operating activities for the year-to-date period was ¥56,559.01 million, showing a decrease of 11.81% compared to the previous year[5] - The company's total assets at the end of the reporting period were ¥1,935,412.07 million, reflecting a slight increase of 0.16% from the end of the previous year[5] - The company's total assets amounted to ¥19,354,120,724.60, slightly up from ¥19,322,830,492.45 in the previous year[20] - The company's cash and cash equivalents were not explicitly detailed, but total current assets reached ¥5,553,637,652.10, up from ¥5,371,465,585.50[20] - Cash and cash equivalents at the end of the period amounted to ¥2,103,077,609.13, an increase from ¥1,902,321,026.71 at the end of the same period last year[28] - The company experienced a net increase in cash and cash equivalents of ¥100,109,176.93, contrasting with a decrease of ¥293,061,180.89 in the previous year[28] Liabilities and Equity - Total liabilities increased to ¥11,163,804,716.51 from ¥10,989,067,038.38, reflecting a growth of 1.6%[19] - The company's long-term borrowings decreased to ¥2,005,080,485.81 from ¥2,274,935,485.81, a reduction of 11.8%[19] - The total equity attributable to shareholders decreased to ¥7,233,616,638.57 from ¥7,337,730,930.43, a decline of 1.4%[20] Cash Flow Activities - Net cash flow from operating activities was ¥565,590,130.45, down 11.83% from ¥641,346,855.79 in the previous year[26] - Total cash inflow from financing activities was ¥1,850,000,000.00, slightly up from ¥1,815,062,659.81 in the previous year[28] - Net cash flow from investing activities was -¥646,399,136.75, an improvement from -¥1,752,557,242.91 in the same period last year[26] - The total cash outflow for operating activities was ¥2,141,414,955.42, compared to ¥1,773,033,508.80 in the same period last year[26] - The company did not report any net profit from subsidiaries prior to consolidation, maintaining a consistent performance in this area[23]

Financial Performance - The company's operating revenue for the third quarter reached ¥376,780,219.70, representing a year-on-year increase of 94.87%[5] - The net profit attributable to shareholders was ¥5,282,105.07, a significant increase of 107.59% compared to the same period last year[5] - The basic earnings per share were ¥0.01, reflecting an increase of 108.11% year-on-year[5] - The company's revenue for the year-to-date period was ¥928,656,487.73, reflecting a 36.16% increase compared to the same period last year[11] - Total operating revenue for the current period reached ¥928,656,487.73, a significant increase from ¥682,024,221.17 in the previous period, representing a growth of approximately 36.2%[27] - The company reported a net loss of ¥88,129,523.65 for the current period, compared to a net loss of ¥145,597,311.36 in the previous period, representing a 39.5% improvement in net loss year-over-year[28] - The total comprehensive income for the current period was -¥72,908,161.60, compared to -¥145,595,754.68 in the previous period, indicating a 50% reduction in comprehensive loss[28] Cash Flow and Assets - The company reported a net cash flow from operating activities of -¥127,788,342.03, indicating a substantial decline of 1,969.65% year-to-date[5] - Cash and cash equivalents decreased significantly from ¥627,730,782.83 to ¥401,014,143.15, a drop of approximately 36.1%[25] - Cash and cash equivalents at the end of the period stood at ¥401,002,636.08, down from ¥527,878,156.98, representing a decrease of approximately 24%[30] - The total current assets decreased to ¥2,670,038,946.39 from ¥2,805,604,440.14, a decline of approximately 4.8%[25] - The total non-current assets increased to ¥1,705,737,869.96 from ¥1,476,502,530.70, showing a growth of about 15.5%[25] - Total liabilities rose to ¥1,812,081,262.24 from ¥1,645,053,066.13, an increase of approximately 10.2%[25] - The total equity attributable to shareholders decreased to ¥2,386,833,733.54 from ¥2,461,468,755.95, reflecting a decline of about 3.0%[26] Shareholder Information - Total number of common shareholders at the end of the reporting period is 25,603[13] - The largest shareholder, Wang Bin, holds 19.35% of shares, totaling 104,957,909 shares[13] - The top 10 shareholders hold a combined total of 186,000,000 shares, representing a significant portion of the company's equity[14] - The total number of shares held by the top 10 unrestricted shareholders is 104,000,000 shares[14] - The company has no preferred shareholders or related party transactions among the top shareholders[15] Operating Costs and Expenses - Operating costs increased by 41.01% year-on-year, totaling ¥556,819,981.38, driven by higher revenue[11] - Total operating costs increased to ¥1,019,409,866.18 from ¥834,692,747.96, reflecting a rise of about 22.1%[27] - The company incurred total operating expenses of ¥943,892,404.55, which is an increase from ¥852,270,933.75 in the previous period, reflecting a rise of about 10.8%[29] - Financial expenses rose by 50.87% to ¥26,167,826.17, attributed to increased loan scales and interest expenses[11] Research and Development - Research and development expenses amounted to ¥296,973,677.27, slightly up from ¥293,150,744.86, indicating a focus on innovation[27] - The company has decided to postpone the "R&D Center Construction Project" completion date to April 2026 due to macroeconomic and market conditions[20] - The company maintains that the postponed R&D project still aligns with its strategic planning and remains necessary and feasible[20] - The company has approved a new stock incentive plan and employee stock ownership plan for 2025[18] Investment Activities - The company generated cash inflows from investment activities totaling ¥444,103,459.15, compared to ¥430,188,974.32 in the previous period, showing a slight increase of 3.2%[30] - The company reported a net investment income of ¥1,850,732.35, down from ¥3,103,347.52, reflecting a decrease of approximately 40.3%[27] Financial Management - The company emphasizes strict management and efficient use of raised funds to mitigate investment risks[20] - The company’s total liabilities increased, impacting its financial leverage and cash flow management strategies moving forward[31]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 北京中石伟业科技股份有限公司 2025 年第三季度报告 证券代码：300684 证券简称：中石科技 公告编号：2025-062 北京中石伟业科技股份有限公司 2025 年第三季度报告 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 北京中石伟业科技股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 550,218,921.11 | ...

Financial Performance - The company's revenue for Q3 2025 reached ¥1,480,953,071.65, representing a year-on-year increase of 14.61%[5] - Net profit attributable to shareholders was ¥3,821,645,576.84, a significant increase of 598.38% compared to the same period last year[5] - The basic earnings per share (EPS) for the period was ¥2.23, reflecting a 596.88% increase year-on-year[5] - Revenue for the first nine months of 2025 reached ¥3,977,176,152.28, representing a 15.05% increase compared to ¥3,457,003,679.89 in the same period of 2024[12] - The net profit for the current period reached ¥4,700,341,438.71, compared to ¥1,521,576,890.64 in the previous period, indicating a significant increase of about 208.5%[32] - The basic and diluted earnings per share for the current period were both ¥2.74, up from ¥0.88 in the previous period, reflecting a growth of approximately 209.1%[32] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥42,036,686,187.33, up 34.26% from the end of the previous year[5] - The company’s total liabilities increased to 26,286,889,552.61 RMB from 19,758,779,691.39 RMB, marking an increase of approximately 33%[28] - The company’s non-current assets totaled 32,397,257,747.81 RMB, up from 22,367,923,551.44 RMB, reflecting a growth of about 45%[27] Cash Flow - The company reported a 140.05% increase in net cash flow from operating activities, totaling ¥2,763,993,203.37[5] - Cash flow from operating activities generated a net amount of ¥2,763,993,203.37, compared to ¥1,151,431,283.62 in the previous period, marking an increase of about 140.5%[35] - Cash flow from investing activities resulted in a net outflow of ¥5,533,123,348.13, worsening from a net outflow of ¥3,751,538,577.82 in the previous period[35] - Cash flow from financing activities generated a net inflow of ¥2,585,838,889.71, down from ¥3,911,085,384.04 in the previous period, indicating a decrease of approximately 33.9%[35] Investment and Expenses - Long-term equity investments surged by 65,620.06% to ¥1,544,229,120.74, due to the acquisition of shares in a REIT[9] - R&D expenses rose by 37.41% to ¥144,632,343.44, up from ¥105,258,580.28, reflecting increased investment in research and development[12] - Operating costs increased by 38.77% to ¥2,063,599,882.28 from ¥1,487,054,788.99, primarily due to successful business expansion[12] - The company reported a significant increase in income tax expenses by 631.02% to ¥430,127,977.92, up from ¥58,839,827.75, related to the transfer of a subsidiary[12] - The company reported investment income of ¥3,759,179,393.95, a substantial increase from ¥12,629,006.64 in the previous period[31] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 87,816[17] - The total number of shares held by major shareholders includes 967,135,107 shares held by Jingjinji Runze (Langfang) Digital Information Co., Ltd.[18] - The company has a total of 1,052,452,523 restricted shares at the beginning of the period, with 967,135,107 shares released during the period, resulting in 0 restricted shares remaining[19] - The company plans to release shares held by major shareholders on August 8, 2025, as part of an asset acquisition transaction[19] - The major shareholder Ningbo Darong Mingchen Venture Capital Partnership (Limited Partnership) holds 50,031,000 shares, which are subject to a lock-up period until August 8, 2025[20] - The company completed the repurchase and cancellation of 85,317,416 shares at a total price of RMB 1.00, as part of a performance commitment compensation agreement[21] - The total number of shares repurchased includes 1,290,775 shares from Qiongcheng Runxiang Investment Partnership (Limited Partnership) and 370,399 shares from Beijing Tianxing Huishi Municipal Engineering Co., Ltd.[21] - The company has implemented a stock incentive plan with a total of 3,096,000 shares subject to restrictions[20] Future Plans and Strategies - The company aims to enhance its operational capabilities through the establishment of a light-asset capital operation platform, which is a significant breakthrough in asset securitization[23] - The company plans to use between 5 billion RMB and 10 billion RMB for share repurchase, with a maximum repurchase price set at 75.00 RMB per share[24] - The company successfully raised a total of 4.5 billion RMB through the issuance of the Southern Runze Technology Data Center REIT, with a total of 1 billion fund shares sold at a price of 4.5 RMB per share[23]

Financial Performance - The company's revenue for Q3 2025 was ¥73,634,583.96, a decrease of 3.58% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥904,655.63, representing a 9.84% increase in loss year-over-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥2,576,218.08, an increase in loss of 29.08% compared to the previous year[5]. - The basic and diluted earnings per share were both -¥0.0056, reflecting an 11.11% improvement in loss compared to the same period last year[5]. - Total operating revenue for the current period was ¥228,414,862.64, a slight decrease from ¥228,744,341.01 in the previous period, representing a decline of approximately 0.14%[18]. - Net profit for the current period was a loss of ¥11,571,407.58, compared to a profit of ¥14,027,447.67 in the previous period, indicating a significant decline[19]. Assets and Liabilities - Total assets at the end of the reporting period were ¥925,406,528.97, a decrease of 0.83% from the end of the previous year[5]. - The company's total assets decreased to ¥925,406,528.97 from ¥933,166,569.41, reflecting a reduction of approximately 0.8%[17]. - Current assets increased to ¥534,992,432.67 from ¥515,196,124.27, showing a growth of about 3.5%[16]. - The company's total liabilities rose to ¥173,199,761.72 from ¥166,415,829.70, an increase of approximately 4.7%[17]. - The company's total equity attributable to shareholders decreased by 2.11% to ¥748,207,707.63 compared to the end of the previous year[5]. - The company's total equity decreased to ¥752,206,767.25 from ¥766,750,739.71, a decline of about 1.9%[18]. Cash Flow - The company's cash flow from operating activities showed a net outflow of -¥1,820,451.14, which is an improvement of 85.25% compared to the previous year[5]. - The net cash flow from operating activities improved by 85.25%, reaching -1,820,451.14, attributed to reduced cash payments for purchasing Chinese medicinal materials and increased collections from accounts receivable[9]. - Cash inflow from operating activities totaled 246,300,713.20 CNY, an increase from 229,823,388.87 CNY in the previous period, representing an increase of approximately 7.5%[20]. - Cash outflow from operating activities was 248,121,164.34 CNY, compared to 242,164,560.28 CNY in the previous period, resulting in a net cash flow from operating activities of -1,820,451.14 CNY, an improvement from -12,341,171.41 CNY[20]. - The net cash flow from investing activities decreased by 172.00%, totaling -10,584,071.39, primarily due to a reduction in the scale of redeeming financial products[9]. - Cash inflow from investment activities was 113,220,646.68 CNY, down from 161,551,091.36 CNY in the previous period, a decrease of approximately 29.9%[21]. - Cash outflow from investment activities totaled 123,804,718.07 CNY, compared to 146,850,820.49 CNY in the previous period, leading to a net cash flow from investment activities of -10,584,071.39 CNY, a decline from 14,700,270.87 CNY[21]. - The net cash flow from financing activities improved by 62.47%, amounting to -5,108,269.87, mainly due to decreased dividend distribution expenses[9]. - Cash inflow from financing activities was 5,170,000.00 CNY, an increase from 3,400,000.00 CNY in the previous period, representing a growth of approximately 52.2%[21]. - Cash outflow from financing activities was 10,278,269.87 CNY, down from 17,010,060.96 CNY in the previous period, resulting in a net cash flow from financing activities of -5,108,269.87 CNY, an improvement from -13,610,060.96 CNY[21]. Investments and Business Activities - The company established a new health management company with a registered capital of RMB 1 million, holding a 19% stake, focusing on health diagnosis services[13]. - The company formed a joint venture for ophthalmic diagnosis services with a registered capital of RMB 2 million, also holding a 19% stake[13]. - The company transferred 100% equity of Jiangxi Yuanqifu Pharmacy Chain Co., Ltd. for RMB 750,000, which will no longer be included in the consolidated financial statements[14]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,433[11]. - The largest shareholder, Guangdong Jino Health Technology Co., Ltd., holds 45.00% of the shares, amounting to 72,000,000 shares[11]. Expenses and Financial Management - Financial expenses increased by 162.77% to ¥987,915.22 due to new business expansion and increased rental costs[8]. - Investment income decreased by 55.49% to ¥3,728,443.65, primarily due to reduced idle funds available for investment and losses from joint ventures[8]. - The fair value change income decreased by 70.51%, amounting to 461,965.43, primarily due to reduced idle funds available for financial management as the company expanded new businesses[9]. - Credit impairment losses increased by 122.28%, totaling -291,888.35, mainly due to an increase in accounts receivable leading to higher bad debt provisions[9]. - Research and development expenses for the current period were ¥6,675,637.43, slightly up from ¥6,416,666.62 in the previous period[18]. Audit Information - The company did not undergo an audit for the third quarter financial report[22].

慕思健康睡眠股份有限公司 2025 年第三季度报告 证券代码：001323 证券简称：慕思股份 公告编号：2025-067 慕思健康睡眠股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 慕思健康睡眠股份有限公司 2025 年第三季度报告 一、主要财务数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 1,283,513,922.80 | 2.7 ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥242,187,452.09, representing a year-on-year increase of 2.85%[5] - The net profit attributable to shareholders for Q3 2025 was ¥30,686,805.67, a decrease of 19.32% compared to the same period last year[5] - The basic earnings per share for Q3 2025 was ¥0.3738, down 19.32% year-on-year[5] - Total revenue for the current period reached ¥692,986,556.95, an increase from ¥673,264,845.48 in the previous period, representing a growth of approximately 1.07%[22] - The company's net profit for the current period is 92,296,632.73 CNY, compared to 91,240,143.27 CNY in the previous period, reflecting an increase of approximately 1.16%[23] - The company reported total operating income of 677,449,990.25 CNY, up from 649,819,887.98 CNY in the previous period, representing an increase of about 4.1%[25] - The total profit before tax for the current period is 106,468,382.53 CNY, slightly down from 106,737,380.62 CNY in the previous period, indicating a decrease of about 0.25%[23] Assets and Liabilities - Total assets at the end of Q3 2025 reached ¥1,291,436,980.61, an increase of 81.39% compared to the end of the previous year[5] - Total assets increased to ¥1,291,436,980.61 from ¥711,957,556.56, reflecting a growth of approximately 81.3%[21] - Current assets rose significantly to ¥1,229,845,158.78, up from ¥654,483,952.12, marking an increase of about 87.5%[20] - The total liabilities decreased to ¥245,560,362.05 from ¥275,935,053.38, a reduction of about 11%[21] Cash Flow - The company's cash flow from operating activities for the first nine months of 2025 was ¥91,194,052.99, up 111.00% year-on-year[13] - Operating cash flow for the current period is 91,194,052.99 CNY, significantly up from 43,220,486.81 CNY in the previous period, indicating a year-over-year increase of over 111%[25] - Total cash and cash equivalents at the end of the period reached 826,362,369.13 CNY, compared to 231,816,537.50 CNY at the end of the previous period, marking an increase of approximately 256%[26] - Cash and cash equivalents surged to ¥826,362,369.35 from ¥279,588,883.58, an increase of approximately 195.5%[20] Shareholder Information - Total number of common shareholders at the end of the reporting period is 27,592[15] - The largest shareholder, Duan Youtao, holds 28.36% of shares, totaling 31,200,000 shares[15] - The second-largest shareholder, Zhang Lingli, holds 24.00% of shares, totaling 26,400,000 shares[15] - The total number of restricted shares at the beginning of the period was 82,100,000, with 4,851,934 new restricted shares added, bringing the total to 86,951,934[17] - The company has no preferred shareholders or preferred stockholders in the top 10 list[16] - The company has a significant number of shares held by institutional investors, including Goldman Sachs and Merrill Lynch, with holdings of 232,975 and 157,171 shares respectively[15] - The company plans to release restricted shares for major shareholders on September 26, 2026, and September 26, 2028[17] - There are no changes in the number of shares lent or returned by the top 10 shareholders due to margin trading[16] Inventory and Receivables - The company reported a decrease in inventory by 34.07% to ¥110,181,562.94, primarily due to the recognition of operating revenue[10] - Accounts receivable increased to ¥205,357,782.57 from ¥166,154,087.94, showing a rise of about 23.6%[20] - The company experienced a 37.65% increase in receivables financing, reaching ¥1,583,130.83, attributed to an increase in bank acceptance bills received[10] Capital and Investments - The company's total equity attributable to shareholders increased by 139.87% to ¥1,045,876,618.56 compared to the end of the previous year[5] - The company’s equity attributable to shareholders rose to ¥1,045,876,618.56 from ¥436,022,503.18, an increase of about 140%[22] - The company’s capital reserve increased by 2135.54% to ¥512,586,510.61, mainly due to the premium from the IPO[10] - The company has made a significant investment of 180,000,000.00 CNY in new projects during the current period, compared to no investment in the previous period[25] - Research and development expenses increased to ¥23,878,636.40 from ¥21,480,677.20, reflecting a growth of approximately 11.1%[22] Other Information - The company has not disclosed any new product developments or market expansion strategies in the provided documents[18] - No significant mergers or acquisitions were mentioned in the conference call content[18] - The company has not reported any other comprehensive income for the current and previous periods, maintaining a consistent position[23] - The company has not undergone an audit for the third quarter financial report, which remains unaudited[27]